Phosphorylated mTOR levels in spheroids correlated with AD severity in human postmortem brains, linking pathway activation to disease progression.

Neuropathology Score: 0.500 Price: $0.50 Alzheimer's disease human Status: extracted

What This Experiment Tests

Neuropathology experiment designed to assess clinical efficacy targeting MTOR in human. Primary outcome: Phosphorylated mTOR levels in spheroids correlated with AD severity in human postmortem brains, link

Description

Correlation analysis between phosphorylated mTOR levels and AD severity markers

TARGET GENE
MODEL SYSTEM
human
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
PI3K/AKT/mTOR pathway
SOURCE
pmid_40065072
PRIMARY OUTCOME
Phosphorylated mTOR levels in spheroids correlated with AD severity in human postmortem brains, linking pathway activation to disease progression.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (4)

APOE4-Specific Proteolytic Fragment Inhibition Therapy0.777
APOE-Dependent Autophagy Restoration0.877
Chronic mTORC1-ULK1 signaling blocks autophagy initiation in irradiated pericytes0.578
Metabolic Checkpoint Reprogramming via TREM2-mTOR Axis0.455

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.